Merging Innovation, Translational Medicine, and Entrepreneurship in Biomedical En

融合生物医学领域的创新、转化医学和创业精神

• 批准号: 8265155
• 负责人: Martin L Yarmush
• 金额: $ 4.32万
• 依托单位: RUTGERS, THE STATE UNIV OF N.J.
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-01 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8265155
• 关键词: Accounting; Address; Affect; Biomedical Engineering; Businesses; Case Study; Clinical; Device Designs; Device or Instrument Development; Discipline; Economics; Educational Curriculum; Educational process of instructing; Emerging Technologies; Engineering; Entrepreneurship; Faculty; Familiarity; Goals; Health; Healthcare Industry; Immersion Investigative Technique; Industry; Instruction; Learning; Legal; Marketing; Medical; Mentors; Participant; Patient Care; Patients; Personal Communication; Physicians; Process; Running; Sales; Schools; Solutions; Students; Translations; Universities; Wood material; Work; base; career; clinically significant; commercialization; cost; design; experience; falls; innovation; instructor; lectures; medical schools; operation; programs; skills; translational medicine

DESCRIPTION (provided by applicant): Our proposal aims at redefining the essence of team-based Senior Design projects in Biomedical Engineering and is based on the realization that in addition to the basic technical, communication and interpersonal skills acquired in a typical 4-year engineering curriculum, successful careers in the health industry require an understanding of how a business functions (marketing and sales, accounting and finance, and operations) and familiarity with the legal, regulatory, and economic constraints affecting patient care device design and development. While Biomedical Engineers need not become experts in all the above, it is critical for them to understand and appreciate these issues. The goal of this proposal is to implement a new Senior Design experience for BME students focused on the integration of biomedical engineering and clinical disciplines with translation of innovation to industry. There are three specific aims: Aim 1: To incorporate basic aspects of translational medicine and innovation commercialization into the lecture component of the Senior Design course. The lecture component, which is primarily given in the fall semester of the senior year, will be overhauled to include lectures given by instructors from the medical and business schools. Aim 2: To increase the clinical significance of Senior Design projects offered to BME seniors. Students will be able to apply for a clinical immersion program in the summer prior to their senior year and will be encouraged to identify needs that can be addressed through biomedical engineering solutions. Medical and Business School faculty, as well as industrial advisors will be invited to develop and mentor senior design projects. Aim 3: To provide a path for translation and commercialization for the most successful senior design projects. A selection process will be implemented whereby about 20% of the projects will be selected at the end of the fall semester for matching with an entrepreneurship course where they become case studies for marketing and financial analysis. At the end of the spring, one or two projects will be further evaluated and pushed towards actual commercialization. The program participants will be the entire senior class of BME students at Rutgers, and the program will be run through the collaborative efforts of the Rutgers Center for Innovative Ventures of Emerging Technology, the Department of Biomedical Engineering at Rutgers, the Robert Wood Johnson School of Medicine, and the Rutgers Business School. Students will tremendously benefit from the proposed upgrade to the Senior Design course because they will be working on projects that are better tailored towards the needs of patients and physicians. They will also get a better understanding of the down-to-earth practical - yet critical - non-technical issues that must be considered when designing new products, such as the competition, market acceptance, cost, and other related considerations. PUBLIC HEALTH RELEVANCE: This proposal aims to revamp the team-based Senior Design experience at Rutgers University and better prepare students for the healthcare industry. Besides applying the technical skills that they have learned in their biomedical engineering curriculum, we propose to teach them about business functions and the legal, regulatory, and economic constraints affecting patient care device design and development.

DESCRIPTION (provided by applicant): Our proposal aims at redefining the essence of team-based Senior Design projects in Biomedical Engineering and is based on the realization that in addition to the basic technical, communication and interpersonal skills acquired in a typical 4-year engineering curriculum, successful careers in the health industry require an understanding of how a business functions (marketing and sales, accounting and finance, and operations) and familiarity with the legal, regulatory, and economic constraints影响患者护理设备设计和开发。尽管生物医学工程师不必成为上述所有专家，但对他们来说，了解和欣赏这些问题至关重要。该提议的目标 是为专注于生物医学工程和临床学科整合的BME学生实施新的高级设计经验，并将创新转化为工业。有三个具体的目标：目标1：将转化医学和创新商业化的基本方面纳入高级设计课程的演讲部分。讲座部分主要是在高年级的秋季学期中进行的，将大修，包括医学和商学院的讲师的讲座。目标2：提高向BME老年人提供的高级设计项目的临床意义。学生将能够在大四的夏天申请临床沉浸式计划，并鼓励他们确定可以通过生物医学工程解决方案来满足的需求。医学和商学院的教职员工以及工业顾问将被邀请开发和指导高级设计项目。目标3：为最成功的高级设计项目提供翻译和商业化的途径。将在秋季学期结束时选择大约20％的项目，以便与企业家课程相匹配，其中将成为销售过程中约有20％的项目，其中它们成为营销和财务分析的案例研究。在春季结束时，将进一步评估一个或两个项目，并将其推向实际的商业化。该计划参与者将是Rutgers的BME学生的整个高年级学生，该计划将通过Rutgers创新创新技术中心的合作努力，Rutgers，Robert Wood Johnson医学院生物医学工程系的合作努力，Robert Wood Johnson医学院和Rutgers商学院。学生将从拟议的升级到高级设计课程中受益匪浅，因为他们将在针对患者和医生的需求方面量身定制的项目。他们还将更好地理解在设计新产品（例如竞争，市场接受，成本和其他相关考虑因素）时必须考虑的脚踏实地实用的（但至关重要的非技术问题）。 公共卫生相关性：该提案旨在改善罗格斯大学的基于团队的高级设计经验，并更好地为医疗保健行业做好准备。除了运用他们在生物医学工程课程中学到的技术技能外，我们还建议他们向他们传授业务功能以及影响患者护理设备设计和开发的法律，法规和经济限制。